These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 21348311

  • 1. [Use of an in vitro lipolysis model to evaluate type I lipid formulations].
    Liu Y, Yi T, Huan D, Xiao L, He JK.
    Yao Xue Xue Bao; 2010 Oct; 45(10):1307-11. PubMed ID: 21348311
    [Abstract] [Full Text] [Related]

  • 2. [Establishment and evaluation of a dynamic in vitro intestinal absorption model of lipid formulations].
    Liu Y, Yi T, Di H, Xiao L, He JK.
    Yao Xue Xue Bao; 2011 Aug; 46(8):983-9. PubMed ID: 22007525
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL, Trevaskis NL, Feeney OM, Edwards GA, Perlman ME, Ambler CM, Porter CJH.
    Mol Pharm; 2017 Dec 04; 14(12):4525-4538. PubMed ID: 29076741
    [Abstract] [Full Text] [Related]

  • 6. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
    Fatouros DG, Bergenstahl B, Mullertz A.
    Eur J Pharm Sci; 2007 Jun 04; 31(2):85-94. PubMed ID: 17418543
    [Abstract] [Full Text] [Related]

  • 7. The In Vitro Lipolysis of Lipid-Based Drug Delivery Systems: A Newly Identified Relationship between Drug Release and Liquid Crystalline Phase.
    Xiao L, Yi T, Liu Y, Zhou H.
    Biomed Res Int; 2016 Jun 04; 2016():2364317. PubMed ID: 27294110
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
    Larsen AT, Holm R, Müllertz A.
    Eur J Pharm Biopharm; 2017 Aug 04; 117():308-314. PubMed ID: 28465239
    [Abstract] [Full Text] [Related]

  • 10. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
    Do TT, Van Speybroeck M, Mols R, Annaert P, Martens J, Van Humbeeck J, Vermant J, Augustijns P, Van den Mooter G.
    Int J Pharm; 2011 Jul 29; 414(1-2):118-24. PubMed ID: 21596119
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.
    Sadhukha T, Layek B, Prabha S.
    Drug Deliv Transl Res; 2018 Apr 29; 8(2):375-386. PubMed ID: 28462499
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
    Thomas N, Holm R, Müllertz A, Rades T.
    J Control Release; 2012 May 30; 160(1):25-32. PubMed ID: 22405903
    [Abstract] [Full Text] [Related]

  • 14. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K, Hawley A, Jannin V, Pouton C, Boyd BJ.
    Eur J Pharm Biopharm; 2018 Sep 30; 130():236-246. PubMed ID: 29981444
    [Abstract] [Full Text] [Related]

  • 15. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
    Dening TJ, Joyce P, Prestidge CA.
    J Pharm Sci; 2019 Jan 30; 108(1):295-304. PubMed ID: 30257194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N, Xia D, Holm R, Gan Y, Müllertz A, Yang M, Mu H.
    Eur J Pharm Sci; 2014 Jan 23; 51():204-10. PubMed ID: 24134899
    [Abstract] [Full Text] [Related]

  • 19. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
    Arnold YE, Imanidis G, Kuentz M.
    Drug Dev Ind Pharm; 2012 Oct 23; 38(10):1262-9. PubMed ID: 22206451
    [Abstract] [Full Text] [Related]

  • 20. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.
    Fernandez S, Chevrier S, Ritter N, Mahler B, Demarne F, Carrière F, Jannin V.
    Pharm Res; 2009 Aug 23; 26(8):1901-10. PubMed ID: 19452130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.